Raphael Pharmaceutical Inc.
RAPH · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $15 | $20 | $5 | $31 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $15 | $20 | $5 | $31 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.016 | -0.022 | -0.021 | -0.017 |
| % Growth | 25.1% | -6.3% | -18.4% | – |
| Operating Cash Flow | – | -$0 | – | – |
| Capital Expenditures | – | $0 | – | – |
| Free Cash Flow | – | -$0 | – | – |